Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).

被引：0

作者：

Lalani, Aly-Khan A.

Swaminath, Anand

Pond, Gregory Russell

Morgan, Scott C.

Azad, Arun

Chu, William

Kapoor, Anil

Bonert, Michael

Bramson, Jonathan L.

Surette, Michael G.

Bosse, Dominick

Siva, Shankar

Bjarnason, Georg A.

Gopaul, Darin

Basappa, Naveen S.

Wright, Jim

Hotte, Sebastien J.

机构：

[1] McMaster Univ, Dept Oncol, Juravinski Canc Ctr, Hamilton, ON, Canada

[2] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada

[3] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada

[4] Peter MacCallum Canc Ctr, Div Med Oncol, Melbourne, Vic, Australia

[5] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada

[6] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada

[7] St Josephs Healthcare Hamilton, Dept Pathol, Hamilton, ON, Canada

[8] McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada

[9] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada

[10] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia

[11] Grand River Hosp, Kitchener, ON, Canada

[12] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS750

引用

页数：1

共 50 条

[21] A Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Stage IV NSCLC
Jelinek, M. J.
Melotek, J. M.
Vokes, E. E.
Weichselbaum, R. R.
Chmura, S. J.
Patel, J. D.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1579 - S1580
[22] Randomized phase 2 study of nivolumab with or without ipilimumab combined with stereotactic body radiotherapy in pretreated patients with metastatic biliary tract cancer.
Markussen, Alice
Johansen, Julia S.
Larsen, Finn Ole
Theile, Susann
Hasselby, Jane P.
Willemoe, Gro Linno
Lorentzen, Torben
Madsen, Kasper
Wilken, Eva E.
Geertsen, Poul F.
Behrens, Claus
Svane, Inge Marie
Nielsen, Dorte
Chen, Inna Markovna
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 545 - 545
[23] A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms
Bouligny, Ian M.
Montalban-Bravo, Guillermo
Sasaki, Koji
Daver, Naval
Jabbour, Elias
Alvarado, Yesid
Dinardo, Courtney D.
Ravandi, Farhad
Borthakur, Gautam
Pemmaraju, Naveen
Kadia, Tapan
Masarova, Lucia
Takahashi, Koichi
Andreeff, Michael
Bazinet, Alexandre
Yang, Hui
Kanagal, Rashmi
Pierce, Sherry
Meyer, Meghan
Huang, Xuelin
Garcia-Manero, Guillermo
LEUKEMIA, 2025, 39 (02) : 524 - 528
[24] Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trial
Doyen, Jerome
Dompmartin, Anne
Cruzel, Coralie
Stefan, Dinu
Arnault, Jean-Philippe
Coutte, Alexandre
Picard-Gauci, Alexandra
Mansard, Sandrine
Gleyzolle, Baptiste
Fontas, Eric
Long-Mira, Elodie
Mirabel, Xavier
Mortier, Laurent
Montaudie, Henri
EUROPEAN JOURNAL OF CANCER, 2025, 217
[25] Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Lheureux, Stephanie
Matei, Daniela E.
Konstantinopoulos, Panagiotis A.
Wang, Ben X.
Gadalla, Ramy
Block, Matthew S.
Jewell, Andrea
Gaillard, Stephanie L.
McHale, Michael
McCourt, Carolyn
Temkin, Sarah
Girda, Eugenia
Backes, Floor J.
Werner, Theresa L.
Duska, Linda
Kehoe, Siobhan
Colombo, Ilaria
Wang, Lisa
Li, Xuan
Wildman, Rachel
Soleimani, Shirin
Lien, Scott
Wright, John
Pugh, Trevor
Ohashi, Pamela S.
Brooks, David G.
Fleming, Gini F.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
[26] Extreme hypofractionated stereotactic radiotherapy for elderly prostate cancer patients: side effects preliminary analysis of a phase II trial
Fabiana Gregucci
Roberta Carbonara
Alessia Surgo
Maria Paola Ciliberti
Domenico Curci
Annarita Ciocia
Luciana Branà
Giuseppe Mario Ludovico
Marcello Scarcia
Filippo Portoghese
Morena Caliandro
Elena Ludovico
Eleonora Paulicelli
Fiorella Cristina Di Guglielmo
Ilaria Bonaparte
Alba Fiorentino
La radiologia medica, 2023, 128 : 501 - 508
[27] Extreme hypofractionated stereotactic radiotherapy for elderly prostate cancer patients: side effects preliminary analysis of a phase II trial
Gregucci, Fabiana
Carbonara, Roberta
Surgo, Alessia
Ciliberti, Maria Paola
Curci, Domenico
Ciocia, Annarita
Brana, Luciana
Ludovico, Giuseppe Mario
Scarcia, Marcello
Portoghese, Filippo
Caliandro, Morena
Ludovico, Elena
Paulicelli, Eleonora
Di Guglielmo, Fiorella Cristina
Bonaparte, Ilaria
Fiorentino, Alba
RADIOLOGIA MEDICA, 2023, 128 (04): : 501 - 508
[28] A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study
Bestvina, Christine M.
Pointer, Kelli B.
Karrison, Theodore
Al-Hallaq, Hania
Hoffman, Philip C.
Jelinek, Michael J.
Juloori, Aditya
Melotek, James M.
Murgu, Septimiu
Partouche, Julien
Vokes, Everett E.
Weichselbaum, Ralph R.
Pitroda, Sean P.
Patel, Jyoti D.
Chmura, Steven J.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (01) : 130 - 140
[29] RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer
Wang, Kun
Chen, Yajie
Zhang, Zhiyuan
Wu, Ruiyan
Zhou, Menglong
Yang, Wang
Wan, Juefeng
Shen, Lijun
Zhang, Hui
Wang, Yan
Han, Xu
Wang, Jiazhou
Zhang, Zhen
Xia, Fan
GASTROENTEROLOGY REPORT, 2023, 11
[30] Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma
Hara, Takuto
Furukawa, Junya
Shiraishi, Yusuke
Okamura, Yasuyoshi
Bando, Yukari
Terakawa, Tomoaki
Harada, Kenichi
Nakano, Yuzo
Fujisawa, Masato
INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 746 - 752

← 1 2 3 4 5 →